Background Image

About Apptomics

Achieving Optimal Management
of Chronic Neurological Conditions

Parkinson’s disease affects approximately 7-10 million people worldwide. Current models for disease management require neurologists to rely on patient-reported symptomatic information and in-clinic assessments. The lack of precise information results in missed opportunities for proactive therapy refinement and the potential for sub-optimal outcomes.

Recognizing the need for new mHealth technologies that bridge the gap in healthcare, Apptomics is revolutionizing the way patients and physicians manage chronic neurological conditions by capturing more accurate insights into disease progression. The company’s patent-pending digital solution provides continuous remote health monitoring and secure exchange of both objective and self-reported data collected both during and in between office visits. Neurologists now have access to reliable and rich datasets and actionable insights that can help inform faster interventions, provide more personalized treatment regimens, and reduce overall costs.

Partners & Collaborators

BBK Worldwide

Epilepsy Foundation

Parkinsons Disease Foundation

Scientific Advisors

S. Papapetropoulos MD, PhD
Movement Disorder Specialist
Pharmaceutical Executive

H. Fernandez MD
Professor of Neurology
Cleveland Clinic
Director of Movement Disorders Clinic

Board of Directors
Georgia Mitsi PhD, MBA
Founder and CEO

R&D and Business Development
HUMANA, UnitedBiosource, Boehringer Ingelheim
Responsible for the vision and the strategy of Apptomics by fueling with passion the executive team to further disrupt traditional healthcare approaches. Dedicated wholeheartedly to patients, I am committed to improve their quality of life and health outcomes through scientifically validated mobile applications.


Marty Joyce

Aldeyra Therapeutics Nasdaq: ALDX
EVP CFO BioSphere, Serono North America

Senior executive employed with leading medical device, biotechnology, and pharmaceutical companies from start-up stage to over $500 million in annual revenue. Expertise in mergers and acquisitions, public equity financings, business development, investor relations, SEC reporting, managed care, market research, and biopharmaceutical manufacturing operations.

Bonnie Brescia

Founding Principal, Corporate Development Officer, BBK Worldwide
Founding principal of BBK Worldwide, and a leader in patient recruitment and engagement for more than 35 years. Widely recognized for helping to shape the recruitment discipline and a preeminent voice for patient centricity, her insights regarding the global clinical research community inform the industry and help fuel BBK’s leadership, innovation and global expansion.